Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5188937
Max Phase: Preclinical
Molecular Formula: C15H12N2O3
Molecular Weight: 268.27
Associated Items:
ID: ALA5188937
Max Phase: Preclinical
Molecular Formula: C15H12N2O3
Molecular Weight: 268.27
Associated Items:
Canonical SMILES: COc1cccc(NC(=O)c2noc3ccccc23)c1
Standard InChI: InChI=1S/C15H12N2O3/c1-19-11-6-4-5-10(9-11)16-15(18)14-12-7-2-3-8-13(12)20-17-14/h2-9H,1H3,(H,16,18)
Standard InChI Key: WPSFFKZRZNVSIY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 268.27 | Molecular Weight (Monoisotopic): 268.0848 | AlogP: 3.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 64.36 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.87 | CX Basic pKa: | CX LogP: 2.68 | CX LogD: 2.68 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.79 | Np Likeness Score: -1.66 |
1. Xue Z, Li H, Xie W, Xu Y, Zhou L, Qu ZB.. (2022) Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors., 13 (12.0): [PMID:36518694] [10.1021/acsmedchemlett.2c00308] |
Source(1):